A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancer
- Lindsey E. Minion
- , Jiaru Bai
- , Bradley J. Monk
- , L. Robin Keller
- , Eskander N. Ramez
- , Gareth K. Forde
- , John K. Chan
- , Krishnansu S. Tewari
Research output: Contribution to journal › Article › peer-review
63
Scopus
citations